A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untr
A phase 2 trial of Uliledlimab, Sintilimab, Pemetrexed in non-small-cell lung cancer and small-cell lung cancer, run by TJ Biopharma Co., Ltd., active and no longer recruiting.
Overview
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer is a phase 2 interventional study registered as NCT07005336 by TJ Biopharma Co., Ltd., with 150 participants planned, started 2025-01-09 and due to reach its primary completion in 2026-08-30. Interventions recorded: Uliledlimab, Sintilimab, Pemetrexed, Gemcitabine, Cisplatin Or Carboplatin. Conditions listed: Non Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
Shares TJ Biopharma, Uliledlimab, Non-small-cell lung cancer.
- TrialNeoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer
Shares Sintilimab, Pemetrexed, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Shares Pemetrexed, Gemcitabine, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Sm
Shares Pemetrexed, Gemcitabine, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialStudy of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
Shares Pemetrexed, Gemcitabine, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalen
Shares Pemetrexed, Gemcitabine, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Shares Pemetrexed, Gemcitabine, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialStudy to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [
Shares Pemetrexed, Gemcitabine, Small-cell lung cancer, Non-small-cell lung cancer.